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Mutations in the adaptor molecule LAT can lead to autoimmunity. In this issue of Immunity, Mingueneau et al.
(2009) describe how this may not be a failure of central tolerance.The transmembrane adaptor molecule
LAT (linker for activation of T cells) is crit-
ical for the coordination and fine-tuning of
signals triggered upon T cell activation.
TCR signaling is initiated by Src-family
kinases, which recruit and phosphorylate
the Syk-family kinase Zap-70, which in
turn phosphorylates LAT at conserved
tyrosine residues (Figure 1). Phosphory-
lated LAT recruits a number of signaling
molecules to the plasma membrane,
including PLC-g1, Grb2, Grap, Gads-
SLP76, Vav, Cbl, and the regulatory
subunit of PI3K, forming a multiprotein
complex known as the ‘‘LAT signalo-
some’’ (Malissen et al., 2005). It is from
this complex that TCR activation signals
are propagated, leading to activation
of the mitogen-activated protein kinase
(MAPK) and phosphatidylinositol lipid
signalingpathways resulting inCa2+ influx,
activation of the transcription factorNFAT,
and ultimately, proliferation and expres-
sion of cytokine genes.
LAT is essential for thymic selection as
demonstrated by the complete absence
of peripheral T cells in LAT-deficient mice
resulting from a block at the double-nega-
tive (DN3) stage (Zhang et al., 1999). The
importance of individual tyrosine residues
within LAT has been teased out through
the analysis of gene-targeted mice that
express LAT with specific Tyr to Phe
substitutions, resulting in LAT with dif-
ferent docking capabilities. In particular,
mice homozygous for LAT with a mutated
tyrosine at position 136 (LatY136F/Y136F),
which cannot bind PLC-g, have impaired
signaling and defective T cell develop-
ment and yet, surprisingly, the mice
develop a Th2 ‘‘autoimmune’’ lymphopro-
liferative disorder with excessive amounts
of Th2 cytokines and hypergammaglobu-
linemia G1 and IgE (Malissen et al., 2005).
The underlying mechanisms by which the
Y136F mutation results in lymphoprolifer-
ation are unclear. One potential explana-174 Immunity 31, August 21, 2009 ª2009 Elstion was that there was defective thymic
selection conferred by the mutant Y136F
LAT, resulting in the selection of T cells
expressing TCRs with a higher than
usual affinity for self-antigen, and thus a
tendency for autoreactivity. If this expla-
nation were correct, one would predict
that normal expression of LAT during
thymic selection might prevent develop-
ment of an equivalent autoimmune con-
dition.
In fact, a more complex explanation
seems to underlie the development of
autoimmunity in LATY136 mice as demon-
strated by Mingueneau et al. (2009) in this
issue. The authors created an elegant
in vivo system in which WT LAT is ex-
pressed in the thymus permitting normal
thymic selection, and naive T cells are
subsequently altered to express only the
Y136F LAT variant (LatD/Y136F) or alterna-
tively, are rendered LAT-deficient (LatD/)
once in the periphery by introducing
a loxP-flanked wild-type Lat allele that
also expressed a diptheria toxin receptor
(DTR), Latflox-dtr. The Latflox-dtr locus was
deleted in isolated mature CD4+ T cells
by retroviral transfection of cre recombi-
nase and diptheria toxin treatment, leav-
ing in one case only cells that had the
mutant version of LAT (LatD/Y136F) or in
the other case, no LAT (LatD/). These
cells were then transferred into recipients
(Cd3eD5/D5 mice) that lacked T cells yet
had a normal B cell compartment, a host
environment that mimics that of the
LatY136F/Y136F mice. Strikingly, the com-
plete absence of LAT or expression of
LATY136F solely in mature CD4+ T cells
leads to an identical Th2 pathology as
seen when LatY136F/Y136F was expressed
throughout development. Again, the mice
had a lymphoproliferative disorder with
high amounts of Th2 cytokine production
and polyclonal B cell activation, giving
rise to excessive IgG1 and IgE produc-
tion, a syndrome the authors are pro-evier Inc.posing to call ‘‘LAT signalling pathology,’’
characteristic of a defective LAT signalo-
some. Development of this syndrome
required the T cells to express CD28 and
be triggered by peptide:MHC, but once
activated the cells downregulated TCR
and upregulated CD5 expression, while
maintaining chronic proliferation and cy-
tokine production.
Defects in TCR signaling molecules
other than LAT have also been docu-
mented to give rise to varying degrees of
autoimmune pathologies. For example,
mice with point mutations in Zap-70, such
as Zap70skg (Sakaguchi et al., 2003) or
Zap70mrd/mrt (Siggs et al., 2007), can de-
velop, respectively, rheumatoid arthritis
and hyper-IgE autoimmune syndrome.
Similar to the LatY136F/Y136F mice, the
Zap70skg mutation was thought to al-
low thymic differentiation of clones with
higher affinity for self, because mutations
in both molecules were shown to permit
differentiation of H-Y-specific TCR trans-
genic cells in male mice, which normally
delete such cells. However, the new
findings presented by Mingueneau et al.
(2009) show that even when normal thy-
mic selection processes are retained,
defects in these signaling molecules can
result in autoimmunity.
An alternative explanation might be that
there are negative regulatory functions of
these signaling molecules in peripheral
T cells that are impaired by the mutation.
Multiple feedback loops exist to regulate
signaling, and the best described of these
involve recruitment of negative regu-
lators: phosphatases, such as SHP-1
and PTPN22, or ubiqitin ligases such as
Cbl. Certainly mutations in such mole-
cules have been shown to contribute to
autoimmunity, with a prime case in point
being the recently described mutation in
PTPN22 that has been strongly linked
with a variety of autoimmune diseases in
man (Bottini et al., 2006).
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Figure 1. Models of LAT Signaling in T Cells
As shown on the left, upon T cell stimulation, membrane-associated LAT is phosphorylated by the protein tyrosine kinase Zap-70. Activated LAT recruits a number
of molecules through its conserved tyrosine residues forming the LAT signalosome. When phosphorylated Tyr136 binds PLCg, Ca2+ influx, NFAT activation, and
activation of the ERK pathway ensues. Other pTyr residues at positions 175, 195, and 235 bind the adaptors Gads and Grb2, which recruit SLP76, Vav, and SOS
among other molecules into the complex. SLP76 is involved in the activation of PLCg, while SOS activates the ERK pathway. Under these conditions, both Th1
and Th2 cell differentiation can be initiated. As shown in the center, when Tyr136 is mutated to a Phe (F), PLCg can no longer be recruited to the signalosome
impairing Ca2+ influx, NFAT activation, and PLCg-driven activation of the ERK pathway. ERK activation via LAT-Grb2-SOS may still be active. This crippled
signaling leads to differentiation to the Th2 cell pathway and unrestrained proliferation and cytokine production. As shown on the right, when LAT is absent, down-
stream Ca2+ influx, NFAT activation, or ERK activation is abolished, although TCR-mediated activation of PI3K can still occur, and a similar phenotype to T cells
with the mutant Y136F LAT is observed.How might LAT contribute to negative
regulation in T cells? By virtue of its dock-
ing abilities and transmembrane location,
LAT is in a position to recruit negative
regulators into the correct vicinity to in-
hibit signaling downstream of the TCR.
For example, LAT associates with GADS
and Grb2 facilitating the recruitment of
SLP76 and activation of downstream
signals, but LAT also recruits the adap-
tor protein Gab2, which acts as a scaf-
fold protein for the phosphatase SHP-2
and acts as a negative regulator of
T cells (Yamasaki et al., 2003). The ex-
cessive lymphoproliferation observed in
LatY136F/Y136F, LatD/Y136F, and LatD/mice
strongly suggests that LAT exerts a sup-
pressive function on certain signaling
cascades, which is lost in these mice.
How such a regulatory role might arise
from a partial loss of function of LATY136
is still to be determined. The tyrosine resi-
dues in LAT that are important for the
recruitment of Gab2, via its interaction
with Grb2, are at positions 175 and 195,
and therefore it is unclear how mutating
Tyr136 impacts on recruitment of Gab2
and SHP-2. It may be that different nega-tive regulators bind to Tyr136 or that there
are additional molecules that participate
in recruitment of Gab2 and SHP-2, similar
to the positively acting signalosome in
which GADS binding to Tyr175 and
Tyr195 cooperates with PLCg1 binding
to Tyr136 to recruit SLP-76 and thus
downstream effectors.
Another intriguing question is why do
many of these defects in signaling mole-
cules result in the development of Th2
type cell responses rather than activation
of Th1 or other T cell subsets? Is the Th2
cell pathway a default setting that is auto-
matically chosen when TCR signaling is
suboptimal, whereas a Th1 response re-
quires a stronger TCR signal? Historically,
factors thought to influence the differenti-
ation of naive T cells into either Th1 or Th2
type cells were the cytokine milieu and
the strength of signal through the TCR
(Constant and Bottomly, 1997). It was
proposed that a weak signal would bias
toward a Th2 cell differentiation pathway.
Perhaps by having defective LAT, a
weaker signal is triggered, resulting in
preferential differentiation of a Th2 cell
response. Alternatively, it may be thatImmunity 3properly controlled cellular activation
needs to involve a balanced participation
of multiple pathways, including MAPK,
PLC-g1, Ca2+, PI3K, etc., so that appro-
priate transcription factors can be turned
on and then off again. Given that LAT
pTyr136 recruits and activates PLCg1,
and signaling downstream of PLCg1 is
defective in the LatD/ cells (Mingueneau
et al., 2009), it is of particular interest that
mice with defects in Ca2+-dependent
signaling also give rise to similar Th2 cell
disorders. For example, mice lacking
components of the NFAT complex (NFATp
and NFAT4) have a profound Th2 cell lym-
phoproliferative disorder (Ranger et al.,
1998), as domice lacking the endoplasmic
reticulum Ca2+ sensors, Stromal cell-inter-
action molecules STIM1 and STIM2 (Oh-
Hora et al., 2008), although in the latter
cases a defect in Treg cell pro-duction
mayalsocontribute to thediseaseseverity.
In addition to highlighting a formerly
unappreciated regulatory role for LAT in
TCR signaling, the paper by Mingueneau
et al. (2009) also illustrates a more general
point about the need for careful inter-
pretation of gene-targeted animals with1, August 21, 2009 ª2009 Elsevier Inc. 175
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Previewssevere thymic defects. This study illus-
trates how, as a result of a block in thymic
development, additional functions of the
deleted molecule can be masked in the
periphery, and therefore, both peripheral
and thymic function may need to be eval-
uated separately before a proper under-
standing of the molecular basis for such
autoimmune syndromes can be appreci-
ated.
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tures within cells, including phagosomes
(van Manen et al., 2005), autophago-
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Cross-presentation plays a key role in
the elaboration of a sustained and effi-
cient immune response by enabling the
presentation of exogenous antigens on
MHC class I molecules and CD8+ T cells
stimulation against a variety of pathogens
causing diseases such as tuberculosis,
salmonellosis, and leishmaniasis, as well
as tumor cells. However, exogenous anti-
gens are not uniquely coming from foreign
molecules. ‘‘Exogenous antigens’’ is used
as a term to illustrate that the antigenic
peptides do not come from the antigen-
presenting cell (APC) itself, but rather
from surrounding apoptotic bodies or
cell fragments (self-proteins) internalized
by endocytosis, macropinocytosis, or
phagocytosis, or from microorganisms
(nonself-proteins) engulfed at sites of
infection. These cells or cell fragments are
sequestered in a membrane organelle
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against antigens from exogenous
odies as an unexpected new player
called phagosome in order to promote
the establishment of conditions that will
enable the killing of microorganisms, and
the hydrolytic degradation of the phago-
some content, within a compartment iso-
lated from the rest of the cell. These
conditions are attained by a complex
maturation process allowing the trans-
formation of newly formed phagosomes
into phagolysosomes. Through interac-
tions with subsets of endocytic organelles
and Golgi-derived vesicles, the phago-
some fills with hydrolases and acquires
the molecular machines necessary for the
acidification of its lumen and the genera-
tion of superoxides contributing to its lytic
and microbicidal properties. According to
the classical view on antigen presenta-
tion, peptides from exogenous sources,
generated in endocytic and phagocytic
organelles, are mainly presented on MHC
class II molecules to trigger a CD4+ T cell
response. This contrasts with a second
